We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

383 hedge funds and large institutions have $8.87B invested in United Therapeutics in 2015 Q2 according to their latest regulatory filings, with 70 funds opening new positions, 132 increasing their positions, 138 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

62% more call options, than puts

Call options by funds: $64.9M | Put options by funds: $40M

43% more first-time investments, than exits

New positions opened: 70 | Existing positions closed: 49

5% more funds holding

Funds holding: 366 → 383 (+17)

2% less capital invested

Capital invested by funds: $9.02B → $8.87B (-$146M)

4% less repeat investments, than reductions

Existing positions increased: 132 | Existing positions reduced: 138

33% less funds holding in top 10

Funds holding in top 10: 15 → 10 (-5)

Holders
383
Holders Change
+17
Holders Change %
+4.64%
% of All Funds
10.32%
Holding in Top 10
10
Holding in Top 10 Change
-5
Holding in Top 10 Change %
-33.33%
% of All Funds
0.27%
New
70
Increased
132
Reduced
138
Closed
49
Calls
$64.9M
Puts
$40M
Net Calls
+$24.9M
Net Calls Change
-$9.86M

Top Buyers

Rank Fund Capital Flow
1
PI
Putnam Investments
Massachusetts
+$92.2M
2
Renaissance Technologies
Renaissance Technologies
New York
+$65.7M
3
Deutsche Bank
Deutsche Bank
Germany
+$59M
4
Invesco
Invesco
Georgia
+$57.9M
5
First Trust Advisors
First Trust Advisors
Illinois
+$56.4M

Top Sellers

Rank Fund Capital Flow
1
TCM
TimesSquare Capital Management
New York
-$140M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$134M
3
LSV Asset Management
LSV Asset Management
Illinois
-$116M
4
YCMGA
York Capital Management Global Advisors
New York
-$64.2M
5
CCM
Consonance Capital Management
New York
-$58.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$86.3M +$10.9M +60,646 +14%
TCIM
27
TIAA CREF Investment Management
New York
$76.7M +$39.5M +219,465 +99%
First Eagle Investment Management
28
First Eagle Investment Management
New York
$74.3M +$9.77M +54,300 +15%
CCM
29
Consonance Capital Management
New York
$67.4M -$58.5M -325,000 -46%
Norges Bank
30
Norges Bank
Norway
$67.1M -$3.3M -18,347 -5%
JIM
31
Jupiter Investment Management
United Kingdom
$64.1M +$24.9M +138,674 +60%
Geode Capital Management
32
Geode Capital Management
Massachusetts
$61.5M +$1M +5,583 +2%
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$57.1M -$45.7M -254,033 -44%
RFC
34
Russell Frank Company
Washington
$56.6M -$6.71M -37,294 -10%
Morgan Stanley
35
Morgan Stanley
New York
$49.6M -$4.67M -25,947 -8%
TA
36
Teachers Advisors
New York
$48.5M +$6.83M +37,970 +16%
PC
37
PointState Capital
New York
$47.8M -$21M -116,600 -30%
Lazard Asset Management
38
Lazard Asset Management
New York
$47M +$4.47M +24,835 +10%
New York State Common Retirement Fund
39
New York State Common Retirement Fund
New York
$46.4M +$120K +668 +0.3%
GAM
40
Gotham Asset Management
New York
$45.4M -$5.39M -29,952 -10%
GT
41
Glenmede Trust
Pennsylvania
$45.3M -$549K -3,050 -1%
D.E. Shaw & Co
42
D.E. Shaw & Co
New York
$44.4M +$29.9M +166,415 +187%
CS
43
Credit Suisse
Switzerland
$43.2M +$12.4M +69,133 +39%
T
44
TOBAM
France
$43.1M +$44.6M +248,066 New
BG
45
BlackRock Group
United Kingdom
$40.7M +$20.9M +116,221 +99%
GC
46
Guggenheim Capital
Illinois
$40.5M -$200K -1,113 -0.5%
Allianz Asset Management
47
Allianz Asset Management
Germany
$39.2M -$10.8M -60,243 -21%
Prudential Financial
48
Prudential Financial
New Jersey
$38.3M -$4.45M -24,760 -10%
SM
49
Seminole Management
New York
$37.5M +$22.2M +123,195 +133%
CCI
50
Columbus Circle Investors
$36.5M -$9.05M -50,289 -19%
1
2
3 4 5

UTHR Hedge Fund Activity: Q2 2015 in Review

383 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2015, worth a combined $8.87B — down 1.6% from $9.02B a quarter earlier.

Buyers outnumbered sellers: 70 funds opened new UTHR positions and 49 closed out — a net gain of 21 holders — while 132 added to existing stakes and 138 trimmed.

The largest buyer was Putnam Investments, adding an estimated $92.2M. The largest seller was TimesSquare Capital Management, cutting an estimated $140M.

  • 383 institutional investors held United Therapeutics (UTHR) as of Q2 2015, up from 366 in Q1 2015.
  • Funds reported $8.87B of United Therapeutics stock for Q2 2015, down 1.6% quarter-over-quarter.
  • 70 funds opened new United Therapeutics positions in Q2 2015 and 49 closed out, a net change of +21 holders.
  • The largest United Therapeutics buyer in Q2 2015 was Putnam Investments, an estimated $92.2M added.
  • The largest United Therapeutics seller in Q2 2015 was TimesSquare Capital Management, an estimated $140M sold.

Based on aggregated 13F filings for Q2 2015.